Skip to content

tretoquinol

CAS 30418-38-3
22

Safety score · 0–100

Caution

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

A synthetic beta-2 adrenergic bronchodilator pharmaceutical agent with systemic effects on the cardiovascular and respiratory systems that has no legitimate cosmetic application.

Tretoquinol (or trimetoquinol) is a selective beta-2 adrenergic receptor agonist used as a bronchodilator in the treatment of asthma and COPD. Its pharmacological mechanism of action (catechol-based sympathomimetic) means it affects smooth muscle relaxation throughout the body. Cosmetic use of beta-agonists is not recognized as safe.

Known concerns

  • Beta-2 adrenergic agonist with systemic pharmacological effects
  • Not approved or listed for cosmetic use
  • No safety data for topical cosmetic application

References

EU

EU CosIng database

European Commission cosmetic ingredient registry: regulatory status, restrictions, authorised functions.

Check your shelf

Find tretoquinol in your products.

Scan any cosmetic product with LuxSense to see if it contains tretoquinol and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve, so always read the physical product label and consult a healthcare professional for personal concerns.